{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T16:14:32Z","timestamp":1695744872820},"reference-count":25,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.euroneuro.2012.03.009","type":"journal-article","created":{"date-parts":[[2012,5,7]],"date-time":"2012-05-07T23:02:15Z","timestamp":1336431735000},"page":"892-896","source":"Crossref","is-referenced-by-count":8,"title":["Pre-treatment waking cortisol response and vulnerability to interferon \u03b1 induced depression"],"prefix":"10.1016","volume":"22","author":[{"given":"Jessica","family":"Eccles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Lallemant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farrah","family":"Mushtaq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majella","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Golding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Tibble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inam","family":"Haq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Whale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2012.03.009_bib1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00006842-197705000-00002","article-title":"Cortisol and growth hormone responses to psychological stress during the menstrual cycle","volume":"39","author":"Abplanalp","year":"1977","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.euroneuro.2012.03.009_bib2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.psyneuen.2009.12.007","article-title":"Prospective prediction of major depressive disorder from cortisol awakening responses in adolescence","volume":"35","author":"Adam","year":"2010","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.euroneuro.2012.03.009_bib3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1192\/bjp.178.5.399","article-title":"Tryptophan depletion and its implications for psychiatry","volume":"178","author":"Bell","year":"2001","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.03.009_bib4","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1176\/appi.ajp.160.10.1890","article-title":"Increase in concentration of waking salivary cortisol in recovered patients with depression","volume":"160","author":"Bhagwagar","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.03.009_bib5","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1001\/archinte.165.19.2206","article-title":"Effects of adding ribavirin to interferon to treat chronic hepatitis C infection: a systematic review and meta-analysis of randomized trials","volume":"165","author":"Brok","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.euroneuro.2012.03.009_bib6","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/mp.2008.48","article-title":"Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment","volume":"14","author":"Bull","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.03.009_bib8","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1176\/appi.ajp.160.7.1342","article-title":"Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy","volume":"160","author":"Capuron","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.03.009_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/10253890410001667205","article-title":"The awakening cortisol response: methodological issues and significance","volume":"7","author":"Clow","year":"2004","journal-title":"Stress"},{"key":"10.1016\/j.euroneuro.2012.03.009_bib10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neubiorev.2009.12.011","article-title":"The cortisol awakening response: more than a measure of HPA axis function","volume":"35","author":"Clow","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2012.03.009_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0033291709005558","article-title":"Not fade away: the HPA axis and depression","volume":"40","author":"Cowen","year":"2010","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2012.03.009_bib12","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, management, and treatment of hepatitis C: an update","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.euroneuro.2012.03.009_bib13","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1159\/000126396","article-title":"Interferon-alpha stimulates the hypothalamic-pituitary-adrenal axis in vivo and in vitro","volume":"57","author":"Gisslinger","year":"1993","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.euroneuro.2012.03.009_bib14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2826.2006.01429.x","article-title":"Do corticosteroids damage the brain?","volume":"18","author":"Herbert","year":"2006","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.euroneuro.2012.03.009_bib15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jpsychores.2007.05.013","article-title":"Depression following pegylated interferon-alpha: characteristics and vulnerability","volume":"63","author":"Lotrich","year":"2007","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.euroneuro.2012.03.009_bib16","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tins.2008.06.006","article-title":"The HPA axis in major depression: classical theories and new developments","volume":"31","author":"Pariante","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.euroneuro.2012.03.009_bib17","first-page":"137","article-title":"A functional serotonin transporter gene polymorphism and depressive effects associated with interferon-alpha treatment","volume":"51","author":"Pierucci-Lagha","year":"2010","journal-title":"Psychosomatics"},{"key":"10.1016\/j.euroneuro.2012.03.009_bib18","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1016\/S0024-3205(97)01008-4","article-title":"Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity","volume":"61","author":"Pruessner","year":"1997","journal-title":"Life Sci."},{"key":"10.1016\/j.euroneuro.2012.03.009_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","article-title":"Cytokines sing the blues: inflammation and the pathogenesis of depression","volume":"27","author":"Raison","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.euroneuro.2012.03.009_bib20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/mp.2008.58","article-title":"Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior","volume":"15","author":"Raison","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.03.009_bib21","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/jnci\/92.12.994","article-title":"Diurnal cortisol rhythm as a predictor of breast cancer survival","volume":"92","author":"Sephton","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.euroneuro.2012.03.009_bib22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1192\/bjp.180.2.168","article-title":"Bio-social origins of depression in the community. Interactions between social adversity, cortisol and serotonin neurotransmission","volume":"180","author":"Strickland","year":"2002","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.03.009_bib23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.encep.2007.09.007","article-title":"Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients","volume":"35","author":"Vignau","year":"2009","journal-title":"Encephale"},{"key":"10.1016\/j.euroneuro.2012.03.009_bib24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1017\/S0033291704003526","article-title":"Early increase in vegetative symptoms predicts IFN-alpha-induced cognitive-depressive changes","volume":"35","author":"Wichers","year":"2005","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2012.03.009_bib25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jpsychores.2006.09.007","article-title":"Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisol","volume":"62","author":"Wichers","year":"2007","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.euroneuro.2012.03.009_bib26","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.pnpbp.2010.04.011","article-title":"Glucocorticoids, cytokines and brain abnormalities in depression","volume":"35","author":"Zunszain","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X12000806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X12000806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T10:56:08Z","timestamp":1542970568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X12000806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0924977X12000806"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2012.03.009","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}